Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| LASTACAFT® (Alcaftadine 0.25%) | One drop of alcaftadine 0.25% ophthalmic solution instilled in each eye at Day 0 and Day 14. | None | None | 0 | 43 | 0 | 43 | View |
| Pataday™ (Olopatadine 0.2%) | One drop of olopatadine 0.2% ophthalmic solution instilled in each eye at Day 0 and Day 14. | None | None | 0 | 42 | 0 | 42 | View |
| Placebo (Dextran 70 0.1%/Hydroxypropyl Methylcellulose 0.3%) | One drop of placebo instilled in each eye at Day 0 and Day 14. | None | None | 0 | 41 | 0 | 41 | View |